TABLE 3.
Diagnosis | R(x): N = 70 | R(+): N = 10 | R(−): N = 10 |
---|---|---|---|
Defects with poor production of specific IgG | |||
ZAP70 mutation | 2 | 1§ | |
CD40 ligand deficiency | 4 | 1‡ | |
IKBa deficiency | 1 | ||
PIK3CD mutation | 1 | ||
STAT3 GOF mutation | 1 | ||
IPEX syndrome | 1 | 1‡ | |
XLP | 3 | 1§ | |
SCID | 41 | ||
WAS | 11 | ||
Cartilage Hair Hypoplasia | 2 | 1§ | |
CID (not known gene defect) | 1‡ | ||
Defects with intact production of specific IgG | |||
Chediak-Higashi syndrome | 1 | ||
Dyskeratosis congenita | 1† | ||
C1q deficiency | 1† | ||
HLH | 1† | 5 | 3 |
CGD | 1 | 1 | |
Congenital neutropenia | 1 | ||
IL-10R deficiency | 1 | 1 |
Note: Distribution of PIDDs by serostatus: PIDDs has been divided into two none: defects in production of specific IgG and capable of production of specific IgG.
Abbreviations: CGD, chronic granulomatous diseasCID, combined immunodeficiency; HLH, hemophagocytic lymphohistiocytosis; IPEX, Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome; PIDDs, primar y immunodeficiency disorders; R(−), seronegative; R(+), seropositive; R(x), unknown CMV serostatus; SCID, Severe combined Immunodeficiency; WAS, Wiskott-Aldrich syndrome; XLP, X-linked lymphoproliferative syndrome.
CMV IgG + and no passive immunity.
CMV IgG + while on IVIg.
Despite the underlying defect, these patients demonstrated specific antibodies to tetanus, diphtheria, and pneumococcal vaccines.